Status:
COMPLETED
Tailored Juice-guided Eradication Therapy
Lead Sponsor:
Kaohsiung Medical University
Conditions:
Helicobacter Pylori Infection
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
In this study, the investigators aim to investigate the efficacy of tailored anti-microbial susceptibility guided-therapy via gastric juice PCR, compared with empirical standard triple therapy.
Detailed Description
The eradication of H. pylori is an important clinical issue due to its association with many gastrointestinal diseases such as peptic ulcer and even gastric cancer. However, with the global trend of i...
Eligibility Criteria
Inclusion
- male or non-pregnant female aged more than 20 yeasrs
- H.pylori infection
- Mental and legal ability to give a written infomed consent
Exclusion
- pregnant women
- previous allergic reaction to antibiotics (clarithromycin, amoxicillin, levofloxacin, metronidazole and Proton-pump inhibitor(rabeprazole)
- patients with previous gastric surgery
- the coexistence of serious concomitant illness(for example, decompensated liver cirrhosis, uremia)
Key Trial Info
Start Date :
February 5 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2019
Estimated Enrollment :
182 Patients enrolled
Trial Details
Trial ID
NCT04061447
Start Date
February 5 2016
End Date
July 31 2019
Last Update
August 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Medical University Hospital
Kaohsiung City, Taiwan, 807